Revolutionizing oncology treatment through precision medicine GenAI elements, with the large-scale deployment of the Integrated Theranostic Oncology Platform

Expertise and Resources Driving Innovation with Collaborative Partnerships Open for Partnerships We are seeking partners in the following domains:

• AI and Data Science Firms: deploying predictive analytics and ML models for RLT process optimization.

• Healthcare Providers: validating ITOP in a clinical setting, providing feedback, and assisting in system optimization.

• Academic and Research Institutions: supporting with validation trial design, executing real-world evidence research on RLT patient data collected through ITOP.

• Technology Firms: developing platform architecture, HIS integrations, platform localization to meet local requirements.

• Regulatory Authorities: ensuring compliance and paving pathways for global scalability.

• SMEs: specialized expertise in IT systems, AI, and healthcare technology.

• Patient Advocacy Groups: providing insights into patient needs, promoting adoption, ensuring patient-centered approach to RLT management.

• Health Economics Experts: assessing cost-effectiveness of ITOP implementation and scalability. Advancing Radioligand Therapy Solutions